Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06SVC
|
|||
| Former ID |
DIB013872
|
|||
| Drug Name |
M-0011
|
|||
| Synonyms |
N-0011; RhLAMAN, Zymenex; Recombinant human alpha-mannosidase (alpha mannosidosis), Zymenex
Click to Show/Hide
|
|||
| Indication | Alpha-mannosidosis [ICD-11: 5C56.21] | Phase 3 | [1] | |
| Company |
Zymenex A/S
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Alpha-mannosidase (MANA) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01908712) Lamazym Aftercare Study FR. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT01681953) A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.